Multicenter Surveillance of Streptococcus pneumoniae Isolates From Middle Ear and Mastoid Cultures in the 13-Valent Pneumococcal Conjugate Vaccine Era
Author(s) -
Sheldon L. Kaplan,
Kimberly J. Center,
William J. Barson,
Philana Ling-Lin,
José R. Romero,
John S. Bradley,
Tina Q. Tan,
Jill A. Hoffman,
Timothy R. Peters,
Alejandra Gurtman,
Daniel A. Scott,
James Trammel,
William C. Gruber,
Kristina G. Hultén,
Edward O. Mason
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ067
Subject(s) - streptococcus pneumoniae , pneumococcal conjugate vaccine , serotype , medicine , penicillin , otitis , mastoiditis , pneumococcal infections , microbiology and biotechnology , conjugate vaccine , antibiotics , virology , biology , surgery
Streptococcus pneumoniae is a common cause of otitis media (OM) in children; mastoiditis remains an important complication of OM. Limited data are available on the impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal otitis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom